Publications

1. Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. Response to Letter to the Editors regarding 'A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis'.. Alcohol and alcoholism (Oxford, Oxfordshire), 2023.
2. Burnette EM, Grodin EN, Olmstead R, Ray LA, Irwin MR. Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge.. Alcohol, clinical & experimental research, 2023.
3. Meredith LR, Hurley B, Friedman TC, Lee ML, Rodriguez L, Lopez B, Mtume N, Dixon T, Belani HK, Hsieh S, Ray LA. Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices.. Journal of addiction medicine, 2023.
4. Ray LA, Nieto SJ, Meredith LR, Burnette E, Donato S, Magill M, Du H. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study.. Psychopharmacology, 2023.
5. Meredith LR, Burnette EM, Nieto SJ, Du H, Donato S, Grodin EN, Green R, Magill M, Baskerville WA, Ray LA. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.. Alcohol (Hanover, York County, Pa.), 2023.
6. Grodin EN, Burnette EM, O'Neill J, Alger J, Ray LA. Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder.. Alcohol and alcoholism (Oxford, Oxfordshire), 2023.
7. Baskerville WA, Grodin EN, Lin J, Miotto K, Mooney LJ, Ray LA. Alcohol Use Among Treatment-Seeking Individuals With Opioid Use Disorder.. Journal of studies on alcohol and drugs, 2023.
8. Lékó AH, Ray LA, Leggio L. The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?. Alcohol (Hanover, York County, Pa.), 2023.
9. Magill M, Kiluk BD, Ray LA. Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate?. Substance abuse and rehabilitation, 2023.
10. MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J. Hazardous drinking and alcohol use disorders.. Nature reviews. Disease primers, 2022.
11. Venegas A, Ray LA. Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach.. Experimental and clinical psychopharmacology, 2022.
12. Nieto SJ, Enders CK, Witkiewitz K, O'Malley SS, Ray LA. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.. Alcoholism, clinical and experimental research, 2022.
13. Ray LA, Nieto SJ, Grodin EN. Translational models of addiction phenotypes to advance addiction pharmacotherapy.. Annals of the New York Academy of Sciences, 2022.
14. Nieto SJ, Grodin EN, Burnette EM, Cahill CM, Ray LA. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.. Alcohol and alcoholism (Oxford, Oxfordshire), 2022.
15. Donato S, Nieto S, Ray LA. The Brief Alcohol Use Disorder Severity Scale: An Initial Validation Evaluation.. Alcohol and alcoholism (Oxford, Oxfordshire), 2022.
16. Grodin EN, Meredith LR, Burnette EM, Miotto K, Irwin MR, Ray LA. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study.. The American journal of drug and alcohol abuse, 2022.
17. Green R, Lin J, Montoya AK, Bello MS, Grodin EN, Ryu H, Ho D, Leventhal AM, Ray LA. Characteristics associated with treatment seeking for smoking cessation among heavy-drinking research participants.. Frontiers in psychiatry, 2022.
18. Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis.. Alcohol and alcoholism (Oxford, Oxfordshire), 2022.
19. Green R, Roche DJO, Ray LA. The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers.. Alcohol and alcoholism (Oxford, Oxfordshire), 2022.
20. Venegas A, Du H, Cooper ZD, Ray LA. Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers.. Addictive behaviors, 2022.
21. Grodin EN, Nieto SJ, Meredith LR, Burnette E, O'Neill J, Alger J, London ED, Miotto K, Evans CJ, Irwin MR, Ray LA. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial.. Addiction biology, 2022.
22. Baskerville WA, Grodin EN, Venegas A, Ray LA. Global sleep quality is associated with tonic craving, but not cue-induced craving.. Addictive behaviors, 2022.
23. Leventhal AM, Cho J, Ray LA, Liccardo Pacula R, Lee BP, Terrault N, Pedersen E, Lee JO, Davis JP, Jin H, Huh J, Wilson JP, Whaley RC. Alcohol use trajectories among U.S. adults during the first 42 weeks of the COVID-19 pandemic.. Alcoholism, clinical and experimental research, 2022.
24. Nieto SJ, Venegas A, Hudson J, Ray LA. Cannabis use and subjective response to alcohol in the human laboratory.. Drug and alcohol dependence, 2022.
25. Meredith LR, Grodin EN, Montoya AK, Miranda R, Squeglia LM, Towns B, Evans C, Ray LA. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.. Alcoholism, clinical and experimental research, 2022.
26. Nieto SJ, Ray LA. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine.. Behavioural brain research, 2022.
27. Nieto SJ, Grodin EN, Ho D, Baskerville WA, Ray LA. Moderators of subjective response to alcohol in the human laboratory.. Alcoholism, clinical and experimental research, 2022.
28. Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.. Drugs, 2022.
29. Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA, Prisciandaro JJ, Wüstenberg T, Anton RF, Bach P, Baldacchino A, Beck A, Bjork JM, Brewer J, Childress AR, Claus ED, Courtney KE, Ebrahimi M, Filbey FM, Ghahremani DG, Azbari PG, Goldstein RZ, Goudriaan AE, Grodin EN, Hamilton JP, Hanlon CA, Hassani-Abharian P, Heinz A, Joseph JE, Kiefer F, Zonoozi AK, Kober H, Kuplicki R, Li Q, London ED, McClernon J, Noori HR, Owens MM, Paulus MP, Perini I, Potenza M, Potvin S, Ray L, Schacht JP, Seo D, Sinha R, Smolka MN, Spanagel R, Steele VR, Stein EA, Steins-Loeber S, Tapert SF, Verdejo-Garcia A, Vollstädt-Klein S, Wetherill RR, Wilson SJ, Witkiewitz K, Yuan K, Zhang X, Zilverstand A. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.. Nature protocols, 2022.
30. Baskerville WA, Friedman TC, Hurley B, Hsieh S, Dixon T, Mtume N, Lee ML, Rodriguez L, Lopez B, Ray LA. Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial.. Trials, 2022.
31. Green R, Montoya AK, Ray LA. The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reduction.. Experimental and clinical psychopharmacology, 2021.
32. Burnette EM, Grodin EN, Eisenberger NI, Ray LA. Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge.. Alcohol and alcoholism (Oxford, Oxfordshire), 2021.
33. Nieto SJ, Venegas A, Burnette EM, MacKillop J, Ray LA. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers.. Psychopharmacology, 2021.
34. Burnette EM, Ray LA, Irwin MR, Grodin EN. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder.. Alcoholism, clinical and experimental research, 2021.
35. Nieto SJ, Grodin EN, Aguirre CG, Izquierdo A, Ray LA. Translational opportunities in animal and human models to study alcohol use disorder.. Translational psychiatry, 2021.
36. Meredith LR, Baskerville WA, Friedman TC, Hurley B, Dixon T, Mtume N, Rodriguez L, Lopez B, Hsieh S, Ray LA. Safety Net Provider Attitudes Toward Smoking Cessation Treatment.. Frontiers in psychiatry, 2021.
37. Donato S, Green R, Ray LA. Alcohol use disorder severity moderates clinical response to varenicline.. Alcoholism, clinical and experimental research, 2021.
38. Venegas A, Donato S, Meredith LR, Ray LA. Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement.. The American journal of drug and alcohol abuse, 2021.
39. Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis.. Alcohol and alcoholism (Oxford, Oxfordshire), 2021.
40. Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. Erratum to: Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis.. Alcohol and alcoholism (Oxford, Oxfordshire), 2021.
41. Grodin EN, Burnette E, Towns B, Venegas A, Ray LA. Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers.. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2021.
42. Meredith LR, Grodin EN, Karno MP, Montoya AK, MacKillop J, Lim AC, Ray LA. Preliminary study of alcohol problem severity and response to brief intervention.. Addiction science & clinical practice, 2021.
43. Meredith LR, Burnette EM, Grodin EN, Irwin MR, Ray LA. Immune treatments for alcohol use disorder: A translational framework.. Brain, behavior, and immunity, 2021.
44. Leventhal AM, Conti DV, Ray LA, Baurley JW, Bello MS, Cho J, Zhang Y, Pester MS, Lebovitz L, Budiarto A, Mahesworo B, Pardamean B. A genetic association study of tobacco withdrawal endophenotypes in African Americans.. Experimental and clinical psychopharmacology, 2021.
45. Green R, Du H, Grodin EN, Nieto SJ, Bujarski S, Roche DJO, Ray LA. A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol.. Alcoholism, clinical and experimental research, 2021.
46. Grodin EN, Burnette EM, Green R, Lim AC, Miotto K, Ray LA. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.. Drug and alcohol dependence, 2021.
47. Nieto SJ, Baskerville W, Donato S, Bujarski S, Ray L. Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use.. The American journal of drug and alcohol abuse, 2021.
48. Grodin EN, Bujarski S, Towns B, Burnette E, Nieto S, Lim A, Lin J, Miotto K, Gillis A, Irwin MR, Evans C, Ray LA. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.. Translational psychiatry, 2021.
49. Ray LA, Green R, Enders C, Leventhal AM, Grodin EN, Li G, Lim A, Hartwell E, Venegas A, Meredith L, Nieto SJ, Shoptaw S, Ho D, Miotto K. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.. The American journal of psychiatry, 2021.
50. Ray LA, Green R, Grodin E. Neurobiological Models of Alcohol Use Disorder in Humans.. The American journal of psychiatry, 2021.
51. Meredith LR, Green R, Grodin EN, Chorpita M, Miotto K, Ray LA. Ibudilast moderates the effect of mood on alcohol craving during stress exposure.. Experimental and clinical psychopharmacology, 2021.
52. Green R, MacKillop J, Hartwell EE, Lim AC, Baskerville WA, Karno M, Ray LA. Behavioral Economic Demand for Alcohol and Cigarettes in Heavy Drinking Smokers: Evidence of Asymmetric Cross-commodity Reinforcing Value.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021.
53. Nieto SJ, Grodin EN, Green R, Ray LA. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers.. Drug and alcohol dependence, 2021.
54. Ray LA, Grodin EN. Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why.. Annual review of clinical psychology, 2021.
55. Baskerville WA, Nieto SJ, Ho D, Towns B, Grodin EN, Li C, Burnette E, Donato S, Ray LA. Baseline Drinking Patterns in Non-Treatment Seeking Problem Drinkers.. Alcohol and alcoholism (Oxford, Oxfordshire), 2021.
56. Ray LA, Du H, Green R, Roche DJO, Bujarski S. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020.
57. Ho D, Towns B, Grodin EN, Ray LA. A novel human laboratory model for screening medications for alcohol use disorder.. Trials, 2020.
58. Burnette EM, Grodin EN, Schacht JP, Ray LA. Clinical and Neural Correlates of Reward and Relief Drinking.. Alcoholism, clinical and experimental research, 2020.
59. Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, London ED. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder.. Drug and alcohol dependence, 2020.
60. Kramer J, Dick DM, King A, Ray LA, Sher KJ, Vena A, Vendruscolo LF, Acion L. Mechanisms of Alcohol Addiction: Bridging Human and Animal Studies.. Alcohol and alcoholism (Oxford, Oxfordshire), 2020.
61. Nieto SJ, Green R, Grodin EN, Cahill CM, Ray LA. Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity.. Drug and alcohol dependence, 2020.
62. Grodin EN, Green RJ, Ray LA. An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol.. Alcoholism, clinical and experimental research, 2020.
63. Nieto SJ, Green R, MacKillop J, Ray LA. Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals With Alcohol Use Disorder.. Alcoholism, clinical and experimental research, 2020.
64. Bello MS, Liautaud MM, De La Cerda JT, Pang RD, Ray LA, Ahluwalia JA, Leventhal AM. Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans.. Addiction (Abingdon, England), 2020.
65. Burnette EM, Baskerville WA, Grodin EN, Ray LA. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.. Trials, 2020.
66. Meredith LR, Lim AC, Ray LA. Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences.. Drug and alcohol dependence, 2020.
67. Grodin EN, Montoya AK, Bujarski S, Ray LA. Modeling motivation for alcohol in humans using traditional and machine learning approaches.. Addiction biology, 2020.
68. Venegas A, Meredith LR, Green R, Cooper ZD, Ray LA. Sex-dependent effects of alcohol administration on the urge to use cannabis.. Experimental and clinical psychopharmacology, 2020.
69. Venegas A, Meredith LR, Cooper ZD, Towns B, Ray LA. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications.. Alcohol and alcoholism (Oxford, Oxfordshire), 2020.
70. Aguirre CG, Stolyarova A, Das K, Kolli S, Marty V, Ray L, Spigelman I, Izquierdo A. Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal.. PloS one, 2020.
71. Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.. JAMA network open, 2020.
72. Magill M, Tonigan JS, Kiluk B, Ray L, Walthers J, Carroll K. The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review.. Behaviour research and therapy, 2020.
73. Lim AC, Green R, Grodin EN, Venegas A, Meredith LR, Donato S, Burnette E, Ray LA. Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration.. Alcoholism, clinical and experimental research, 2020.
74. Lim AC, Grodin EN, Green R, Venegas A, Meredith LR, Courtney KE, Moallem NR, Sayegh P, London ED, Ray LA. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.. The American journal of drug and alcohol abuse, 2020.
75. Ray LA, Grodin EN, Leggio L, Bechtholt AJ, Becker H, Feldstein Ewing SW, Jentsch JD, King AC, Mason BJ, O'Malley S, MacKillop J, Heilig M, Koob GF. The future of translational research on alcohol use disorder.. Addiction biology, 2020.
76. Glasner S, Chokron Garneau H, Ang A, Ray L, Venegas A, Rawson R, Kalichman S. Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial.. PloS one, 2020.
77. Nieto SJ, Grodin EN, Ray LA. On the path towards personalized medicine: Implications of pharmacogenetic studies of alcohol use disorder medications.. Expert review of precision medicine and drug development, 2020.
78. Cummings JR, Ray LA, Nooteboom P, Tomiyama AJ. Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking.. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2020.
79. Grodin EN, Nguyen XT, Ho D, Bujarski S, Ray LA. Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers.. Addictive behaviors reports, 2020.
80. Grodin EN, Bujarski S, Venegas A, Baskerville WA, Nieto SJ, Jentsch JD, Ray LA. Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool.. Alcohol and alcoholism (Oxford, Oxfordshire), 2019.
81. Ray LA, Du H, Grodin E, Bujarski S, Meredith L, Ho D, Nieto S, Wassum K. Capturing habitualness of drinking and smoking behavior in humans.. Drug and alcohol dependence, 2019.
82. Cummings JR, Gearhardt AN, Ray LA, Choi AK, Tomiyama AJ. Experimental and observational studies on alcohol use and dietary intake: a systematic review.. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2019.
83. Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition.. Journal of consulting and clinical psychology, 2019.
84. Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis.. Alcoholism, clinical and experimental research, 2019.
85. Burnette EM, Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. Association between impulsivity and neural activation to alcohol cues in heavy drinkers.. Psychiatry research. Neuroimaging, 2019.
86. Grodin EN, Ray LA. The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review.. Alcoholism, clinical and experimental research, 2019.
87. Cortland CI, Shapiro JR, Guzman IY, Ray LA. The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology.. Addiction (Abingdon, England), 2019.
88. Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, van Holst RJ, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders.. Neuroscience and biobehavioral reviews, 2019.
89. Venegas A, Ray LA. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder.. The American journal of drug and alcohol abuse, 2019.
90. Hartwell EE, Bujarski S, Green R, Ray LA. Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving.. Addictive behaviors reports, 2019.
91. Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention.. Frontiers in psychiatry, 2019.
92. Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis.. Addiction biology, 2019.
93. Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent.. Drug and alcohol dependence, 2019.
94. Green R, Grodin E, Lim AC, Venegas A, Bujarski S, Krull J, Ray LA. The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory.. Alcoholism, clinical and experimental research, 2019.
95. Grodin EN, Courtney KE, Ray LA. Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity.. Journal of studies on alcohol and drugs, 2019.
96. Grodin EN, Ray LA, MacKillop J, Lim AC, Karno MP. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study.. Alcoholism, clinical and experimental research, 2019.
97. Green R, Bujarski S, Lim AC, Venegas A, Ray LA. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.. Experimental and clinical psychopharmacology, 2019.
98. Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ, National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.. Alcoholism, clinical and experimental research, 2018.
99. Ray LA, Lim AC, Shoptaw S. What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'.. Addiction (Abingdon, England), 2018.
100. Lim AC, Roche DJO, Ray LA. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.. Journal of studies on alcohol and drugs, 2018.
101. Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.. The American journal of drug and alcohol abuse, 2018.
102. Cummings JR, Tomiyama AJ, Ray LA. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder.. Journal of addiction medicine, 2018.
103. Lim AC, Courtney KE, Moallem NR, Allen VC, Leventhal AM, Ray LA. A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability.. Frontiers in psychiatry, 2018.
104. Bello MS, McBeth JF, Ditre JW, Kirkpatrick MG, Ray LA, Dunn KE, Leventhal AM. Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers.. Journal of abnormal psychology, 2018.
105. Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder.. Alcoholism, clinical and experimental research, 2018.
106. Allen VC, Ray LA, Myers HF. Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men.. Alcoholism, clinical and experimental research, 2018.
107. Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018.
108. Hartwell EE, Ray LA. Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers.. Alcohol and alcoholism (Oxford, Oxfordshire), 2018.
109. Green R, Ray LA. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes.. Drug and alcohol dependence, 2018.
110. Moallem NR, Courtney KE, Ray LA. The relationship between impulsivity and methamphetamine use severity in a community sample.. Drug and alcohol dependence, 2018.
111. Hartwell EE, Ray LA. Relationship between tonic and phasic craving for alcohol.. Addictive behaviors reports, 2018.
112. Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.. Alcoholism, clinical and experimental research, 2018.
113. Cservenka A, Courtney KE, Ghahremani DG, Hutchison KE, Ray LA. Development, Initial Testing and Challenges of an Ecologically Valid Reward Prediction Error FMRI Task for Alcoholism.. Alcohol and alcoholism (Oxford, Oxfordshire), 2017.
114. Lim AC, Cservenka A, Ray LA. Effects of Alcohol Dependence Severity on Neural Correlates of Delay Discounting.. Alcohol and alcoholism (Oxford, Oxfordshire), 2017.
115. Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders.. Journal of substance abuse treatment, 2017.
116. Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?. The American journal of drug and alcohol abuse, 2017.
117. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.. Psychopharmacology, 2017.
118. Westman JG, Bujarski S, Ray LA. Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals.. Alcohol and alcoholism (Oxford, Oxfordshire), 2017.
119. Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017.
120. Bullock K, Cservenka A, Ray LA. Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers.. The American journal of drug and alcohol abuse, 2016.
121. Cservenka A, Yardley MM, Ray LA. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.. The American journal on addictions, 2016.
122. Hartwell EE, Moallem NR, Courtney KE, Glasner-Edwards S, Ray LA. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.. Journal of addiction medicine, 2016.
123. Bello MS, Pang RD, Chasson GS, Ray LA, Leventhal AM. Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers.. Journal of anxiety disorders, 2016.
124. Cservenka A, Ray LA. Self-reported attentional and motor impulsivity are related to age at first methamphetamine use.. Addictive behaviors, 2016.
125. Chung T, Noronha A, Carroll KM, Potenza MN, Hutchison K, Calhoun VD, Gabrieli JD, Morgenstern J, Nixon SJ, Wexler BE, Brewer J, Ray L, Filbey F, Strauman TJ, Kober H, Feldstein Ewing SW. Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging Findings.. Current addiction reports, 2016.
126. Courtney KE, Ghahremani DG, Ray LA. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016.
127. Bujarski S, Ray LA. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research.. Behaviour research and therapy, 2016.
128. Green R, Bujarski S, Roche DJ, Ray LA. Relationship between negative affect and smoking topography in heavy drinking smokers.. Addictive behaviors, 2016.
129. Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.. Alcoholism, clinical and experimental research, 2016.
130. Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.. Current addiction reports, 2016.
131. Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.. Addiction biology, 2016.
132. Inagaki TK, Ray LA, Irwin MR, Way BM, Eisenberger NI. Opioids and social bonding: naltrexone reduces feelings of social connection.. Social cognitive and affective neuroscience, 2016.
133. Ray LA, Bujarski S, Roche DJ. Subjective Response to Alcohol as a Research Domain Criterion.. Alcoholism, clinical and experimental research, 2016.
134. Squeglia LM, Brammer WA, Ray LA, Lee SS. Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Predict Alcohol Expectancy Development.. Journal of child & adolescent substance abuse, 2015.
135. Moore AA, Karno MP, Ray L, Ramirez K, Barenstein V, Portillo MJ, Rizo P, Borok J, Liao DH, Barron J, del Pino HE, Valenzuela A, Barry KL. Development and Preliminary Testing of a Promotora-Delivered, Spanish Language, Counseling Intervention for Heavy Drinking among Male, Latino Day Laborers.. Journal of substance abuse treatment, 2015.
136. Cummings JR, Ray LA, Tomiyama AJ. Food-alcohol competition: As young females eat more food, do they drink less alcohol?. Journal of health psychology, 2015.
137. Courtney KE, Ray LA. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.. Progress in brain research, 2015.
138. Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA. Neural substrates of cue reactivity: association with treatment outcomes and relapse.. Addiction biology, 2015.
139. Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and Environmental Predictors of Alcohol Use in Asian American Young Adults.. Journal of studies on alcohol and drugs, 2015.
140. Allen VC, Myers HF, Ray L. The Association Between Alcohol Consumption and Condom Use: Considering Correlates of HIV Risk Among Black Men Who Have Sex with Men.. AIDS and behavior, 2015.
141. Bujarski S, Hutchison KE, Prause N, Ray LA. Functional significance of subjective response to alcohol across levels of alcohol exposure.. Addiction biology, 2015.
142. Courtney KE, Ghahremani DG, Ray LA. The effect of alcohol priming on neural markers of alcohol cue-reactivity.. The American journal of drug and alcohol abuse, 2015.
143. Bidwell LC, Knopik VS, Audrain-McGovern J, Glynn TR, Spillane NS, Ray LA, Riggs NR, Guillot CR, Pang RD, Leventhal AM. Novelty Seeking as a Phenotypic Marker of Adolescent Substance Use.. Substance abuse : research and treatment, 2015.
144. Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The Association of Alcohol Severity and Sleep Quality in Problem Drinkers.. Alcohol and alcoholism (Oxford, Oxfordshire), 2015.
145. Bujarski S, Hutchison KE, Roche DJ, Ray LA. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers.. Alcoholism, clinical and experimental research, 2015.
146. Roche DJ, Ray LA. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.. Pharmacogenomics, 2015.
147. Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.. Pharmacology, biochemistry, and behavior, 2015.
148. Ray LA, Bujarski S. Mechanisms of topiramate effects: refining medications development for alcoholism.. Addiction biology, 2015.
149. Sheets ES, Bujarski S, Leventhal AM, Ray LA. Emotion differentiation and intensity during acute tobacco abstinence: A comparison of heavy and light smokers.. Addictive behaviors, 2015.
150. Ray LA. A matter of outlook.. Alcoholism, clinical and experimental research, 2015.
151. Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.. Experimental and clinical psychopharmacology, 2015.
152. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015.
153. Yardley MM, Mirbaba MM, Ray LA. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers.. CNS drugs, 2015.
154. Owens MM, Ray LA, MacKillop J. Behavioral economic analysis of stress effects on acute motivation for alcohol.. Journal of the experimental analysis of behavior, 2014.
155. Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.. Drug and alcohol dependence, 2014.
156. Bacio GA, Guzman IY, Shapiro JR, Ray LA. Differences in quit attempts between non-Hispanic Black and White daily smokers: the role of smoking motives.. Addictive behaviors, 2014.
157. Bujarski S, Ray LA. Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers.. Addictive behaviors, 2014.
158. Sujan AC, Humphreys KL, Ray LA, Lee SS. Differential association of child abuse with self-reported versus laboratory-based impulsivity and risk-taking in young adulthood.. Child maltreatment, 2014.
159. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.. The American journal of drug and alcohol abuse, 2014.
160. Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.. Drug and alcohol dependence, 2014.
161. Bacio G, Moore A, Karno M, Ray L. Determinants of problem drinking and depression among Latino Day laborers.. Substance use & misuse, 2014.
162. Ashenhurst JR, Bujarski S, Jentsch JD, Ray LA. Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): moderation by alcohol problem severity.. Experimental and clinical psychopharmacology, 2014.
163. Courtney KE, Ghahremani DG, London ED, Ray LA. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol.. Drug and alcohol dependence, 2014.
164. DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study.. Journal of studies on alcohol and drugs, 2014.
165. Bujarski S, Ray LA. Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans.. Drug and alcohol dependence, 2014.
166. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.. Psychopharmacology, 2014.
167. MacKillop J, Amlung MT, Acker J, Gray JC, Brown CL, Murphy JG, Ray LA, Sweet LH. The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014.
168. Roche DJ, Bujarski S, Moallem NR, Guzman I, Shapiro JR, Ray LA. Predictors of smoking lapse in a human laboratory paradigm.. Psychopharmacology, 2014.
169. Miranda R, Monti PM, Ray L, Treloar HR, Reynolds EK, Ramirez J, Chun T, Gwaltney CJ, Justus A, Tidey J, Blanchard A, Magill M. Characterizing subjective responses to alcohol among adolescent problem drinkers.. Journal of abnormal psychology, 2014.
170. Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.. Alcohol and alcoholism (Oxford, Oxfordshire), 2014.
171. Ray LA, Roche DJ, Heinzerling K, Shoptaw S. Opportunities for the development of neuroimmune therapies in addiction.. International review of neurobiology, 2014.
172. Courtney KE, Ray LA. Subjective responses to alcohol in the lab predict neural responses to alcohol cues.. Journal of studies on alcohol and drugs, 2014.
173. Lin JC, Karno MP, Grella CE, Ray LA, Liao DH, Moore AA. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2013.
174. Courtney KE, Ashenhurst J, Bacio G, Moallem N, Bujarski S, Hartwell E, Ray LA. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory.. Journal of studies on alcohol and drugs, 2013.
175. Moallem NR, Courtney KE, Bacio GA, Ray LA. Modeling alcohol use disorder severity: an integrative structural equation modeling approach.. Frontiers in psychiatry, 2013.
176. Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.. Alcoholism, clinical and experimental research, 2013.
177. Hartwell EE, Ray LA. Sex moderates stress reactivity in heavy drinkers.. Addictive behaviors, 2013.
178. Bacio GA, Lunny KF, Webb JN, Ray LA. Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals.. The American journal on addictions, 2013.
179. Ray LA, Sehl M, Bujarski S, Hutchison K, Blaine S, Enoch MA. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G × E effects.. Genes, brain, and behavior, 2013.
180. Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.. Addiction biology, 2013.
181. Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.. Drug and alcohol dependence, 2013.
182. Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.. Alcoholism, clinical and experimental research, 2012.
183. Courtney KE, Ghahremani DG, Ray LA. Fronto-striatal functional connectivity during response inhibition in alcohol dependence.. Addiction biology, 2012.
184. Bujarski S, O'Malley SS, Lunny K, Ray LA. The effects of drinking goal on treatment outcome for alcoholism.. Journal of consulting and clinical psychology, 2012.
185. Bholat MA, Ray L, Brensilver M, Ling K, Shoptaw S. Integration of behavioral medicine in primary care.. Primary care, 2012.
186. Miranda R, Reynolds E, Ray L, Justus A, Knopik VS, McGeary J, Meyerson LA. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents.. Alcoholism, clinical and experimental research, 2012.
187. Ashenhurst JR, Bujarski S, Ray LA. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.. Pharmacology, biochemistry, and behavior, 2012.
188. MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, Sweet LH. The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers.. Psychiatry research, 2012.
189. Bujarski S, MacKillop J, Ray LA. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.. Experimental and clinical psychopharmacology, 2012.
190. Moallem NR, Ray LA. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects.. Addictive behaviors, 2012.
191. Tartter MA, Ray LA. A prospective study of stress and alcohol craving in heavy drinkers.. Pharmacology, biochemistry, and behavior, 2012.
192. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research.. Alcoholism, clinical and experimental research, 2012.
193. Heinzerling KG, McCracken JT, Swanson AN, Ray LA, Shoptaw SJ. COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation.. Journal of clinical psychopharmacology, 2012.
194. Ray LA, Courtney KE, Bujarski S, Squeglia LM. Pharmacogenetics of alcoholism: a clinical neuroscience perspective.. Pharmacogenomics, 2012.
195. Leventhal AM, Ray LA, Rhee SH, Unger JB. Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011.
196. Moallem N, Ray LA. Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study.. Pharmacology, biochemistry, and behavior, 2011.
197. Courtney KE, Arellano R, Barkley-Levenson E, Gálvan A, Poldrack RA, Mackillop J, Jentsch JD, Ray LA. The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach.. Alcoholism, clinical and experimental research, 2011.
198. Ashenhurst JR, Jentsch JD, Ray LA. Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers.. Experimental and clinical psychopharmacology, 2011.
199. Hutchison KE, Ray LA. New approaches to identifying rare genetic variants associated with nicotine dependence.. Biological psychiatry, 2011.
200. Ray LA, Bujarski S, Chin PF, Miotto K. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011.
201. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.. Alcoholism, clinical and experimental research, 2011.
202. Tartter MA, Ray LA. The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms.. Frontiers in psychiatry, 2011.
203. Ray LA, Chin PF, Heydari A, Miotto K. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.. Psychopharmacology, 2011.
204. MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munafò MR. Delayed reward discounting and addictive behavior: a meta-analysis.. Psychopharmacology, 2011.
205. Ferriter C, Ray LA. Binge eating and binge drinking: an integrative review.. Eating behaviors, 2011.
206. Ray LA, Hart E, Chelminski I, Young D, Zimmerman M. Clinical correlates of desire for treatment for current alcohol dependence among patients with a primary psychiatric disorder.. The American journal of drug and alcohol abuse, 2011.
207. Leventhal AM, Brightman M, Ameringer KJ, Greenberg J, Mickens L, Ray LA, Sun P, Sussman S. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.. Experimental and clinical psychopharmacology, 2010.
208. Ray LA, Hart EJ, Chin PF. Self-Rating of the Effects of Alcohol (SRE): Predictive utility and reliability across interview and self-report administrations.. Addictive behaviors, 2010.
209. Ray LA, Krull JL, Leggio L. The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.. Frontiers in psychiatry, 2010.
210. Ray LA. Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes.. Alcoholism, clinical and experimental research, 2010.
211. Ray LA, Heydari A, Zorick T. Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature.. Drug and alcohol review, 2010.
212. Ray LA, Mackillop J, Monti PM. Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism.. Substance use & misuse, 2010.
213. MacKillop J, O'Hagen S, Lisman SA, Murphy JG, Ray LA, Tidey JW, McGeary JE, Monti PM. Behavioral economic analysis of cue-elicited craving for alcohol.. Addiction (Abingdon, England), 2010.
214. Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL. Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation.. Alcoholism, clinical and experimental research, 2010.
215. Ray LA, Chin PF, Miotto K. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.. CNS & neurological disorders drug targets, 2010.
216. MacKillop J, Miranda R, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JE, Swift RM, Tidey JW, Gwaltney CJ. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders.. Journal of abnormal psychology, 2010.
217. Ray LA, Miranda R, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.. Journal of abnormal psychology, 2010.
218. Ray LA, Hutchison KE, Tartter M. Application of human laboratory models to pharmacotherapy development for alcohol dependence.. Current pharmaceutical design, 2010.
219. Ray LA, Capone C, Sheets E, Young D, Chelminski I, Zimmerman M. Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample.. Psychiatry research, 2009.
220. Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M. Young Investigator Award symposium.. Alcohol (Fayetteville, N.Y.), 2009.
221. Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM. Initial evidence of an association between OPRM1 and adolescent alcohol misuse.. Alcoholism, clinical and experimental research, 2009.
222. Ray LA, MacKillop J, Leventhal A, Hutchison KE. Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication.. Alcoholism, clinical and experimental research, 2009.
223. Ray LA, Oslin DW. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.. Drug and alcohol dependence, 2009.
224. Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.. Journal of studies on alcohol and drugs, 2009.
225. Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S. Relations between anhedonia and smoking motivation.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009.
226. Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.. Alcoholism, clinical and experimental research, 2009.
227. Ray LA, Hutchison KE. Associations among GABRG1, level of response to alcohol, and drinking behaviors.. Alcoholism, clinical and experimental research, 2009.
228. Ray LA, Miranda R, MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, Gwaltney C, Swift RW, Monti PM. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.. Experimental and clinical psychopharmacology, 2009.
229. Ray LA, Hutchison KE, Leventhal AM, Miranda R, Francione C, Chelminski I, Young D, Zimmerman M. Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications.. Addictive behaviors, 2009.
230. Leventhal AM, Kahler CW, Ray LA, Zimmerman M. Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence.. Addictive behaviors, 2008.
231. Mackillop J, Murphy JG, Tidey JW, Kahler CW, Ray LA, Bickel WK. Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve.. Psychopharmacology, 2008.
232. Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE. Effects of naltrexone on cortisol levels in heavy drinkers.. Pharmacology, biochemistry, and behavior, 2008.
233. Ray LA, Bryan A, Mackillop J, McGeary J, Hesterberg K, Hutchison KE. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects.. Addiction biology, 2008.
234. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.. Alcoholism, clinical and experimental research, 2008.
235. Ray LA, Hutchison KE, MacKillop J, Miranda R, Audette A, Swift R, Monti PM. Effects of naltrexone during the descending limb of the blood alcohol curve.. The American journal on addictions, 2008.
236. Ray LA, Kahler CW, Young D, Chelminski I, Zimmerman M. The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients.. Journal of studies on alcohol and drugs, 2008.
237. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, Zimmerman M. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.. The American journal on addictions, 2008.
238. Ray LA, Miranda R, Chelminski I, Young D, Zimmerman M. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample.. Drug and alcohol dependence, 2008.
239. MacKillop J, Murphy JG, Ray LA, Eisenberg DT, Lisman SA, Lum JK, Wilson DS. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.. Experimental and clinical psychopharmacology, 2008.
240. Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.. Alcoholism, clinical and experimental research, 2008.
241. Miranda R, Rohsenow DJ, Monti PM, Tidey J, Ray L. Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity.. Addictive behaviors, 2007.
242. Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.. Archives of general psychiatry, 2007.
243. Ray LA, Rhee SH, Stallings MC, Knopik V, Hutchison KE. Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study.. Twin research and human genetics : the official journal of the International Society for Twin Studies, 2007.
244. Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.. Psychopharmacology, 2007.
245. Bryan A, Ray LA, Cooper ML. Alcohol use and protective sexual behaviors among high-risk adolescents.. Journal of studies on alcohol and drugs, 2007.
246. Ray LA, MacKillop J, Hutchison KE. Pharmacogenetics of the µ-opioid receptor and the treatment of addictions.. Personalized medicine, 2007.
247. Ray LA, Meskew-Stacer S, Hutchison KE. The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies.. Journal of studies on alcohol and drugs, 2007.
248. Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006.
249. Ray LA, McGeary J, Marshall E, Hutchison KE. Risk factors for alcohol misuse: examining heart rate reactivity to alcohol, alcohol sensitivity, and personality constructs.. Addictive behaviors, 2006.
250. Hines LM, Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes.. Dialogues in clinical neuroscience, 2005.
251. Ray LA, Hutchison KE. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.. Alcoholism, clinical and experimental research, 2004.
252. Fromme K, de Wit H, Hutchison KE, Ray L, Corbin WR, Cook TA, Wall TL, Goldman D. Biological and behavioral markers of alcohol sensitivity.. Alcoholism, clinical and experimental research, 2004.